Skip to Content

Simponi Aria Side Effects

Generic Name: golimumab

Note: This document contains side effect information about golimumab. Some of the dosage forms listed on this page may not apply to the brand name Simponi Aria.

In Summary

Common side effects of Simponi Aria include: infection. Other side effects include: malignant neoplasm. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to golimumab: solution

Along with its needed effects, golimumab (the active ingredient contained in Simponi Aria) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking golimumab:

More Common

  • Body aches or pain
  • chills
  • cough
  • difficulty with breathing
  • ear congestion
  • fever
  • headache
  • loss of voice
  • muscle aches
  • sneezing
  • sore throat
  • stuffy or runny nose
  • unusual tiredness or weakness

Less Common

  • Blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • cough with mucus
  • diarrhea
  • dizziness
  • general feeling of discomfort or illness
  • hoarseness
  • joint pain
  • loss of appetite
  • nasal congestion
  • nausea
  • nervousness
  • pain or tenderness around the eyes and cheekbones
  • painful cold sores or blisters on the lips
  • pounding in the ears
  • shivering
  • slow or fast heartbeat
  • sweating
  • tender, swollen glands in the neck
  • tightness of the chest
  • trouble with sleeping
  • trouble with swallowing
  • voice changes
  • vomiting


  • Bone pain
  • frequent or painful urination
  • redness, soreness, or itching of the skin
  • severe stomach pain
  • sores, welts, or blisters
  • yellow eyes or skin

Incidence Not Known

  • Hives
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • red, scaling, or crusted skin
  • skin rash
  • swelling of the face, throat, or tongue

Some side effects of golimumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less Common

  • Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • burning or stinging of the skin
  • difficulty having a bowel movement

For Healthcare Professionals

Applies to golimumab: intravenous solution, subcutaneous solution


The most common side effects were upper respiratory tract infection, sepsis, increased ALT, increased AST, tuberculosis, and anemia. The most serious side effects were serious infections and malignancies.[Ref]


Very common (10% or more): Upper respiratory tract infections (nasopharyngitis, pharyngitis, laryngitis, and rhinitis) (up to 16%)

Common (1% to 10%): Bronchitis, sinusitis

Uncommon (0.1% to 1%): Lower respiratory tract infection (e.g., pneumonia), asthma and related symptoms (such as wheezing and bronchial hyperactivity), interstitial lung disease

Rare (less than 0.1%): Tuberculosis[Ref]


Uncommon (0.1% to 1%): Neoplasms (e.g., skin cancer, squamous cell carcinoma, melanocytic nevus)

Rare (less than 0.1%): Lymphoma, leukemia, melanoma[Ref]


Common (1% to 10%): Pyrexia, asthenia

Rare (less than 0.1%): Impaired healing[Ref]


Common (1% to 10%): Hypertension

Uncommon (0.1% to 1%): Congestive heart failure (new onset or worsening), arrhythmia, ischemic coronary artery disorders, thrombosis (e.g., deep venous and aortic), Raynaud's phenomenon, flushing, chest discomfort

Rare (less than 0.1%): Vasculitis (systemic)[Ref]

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Demyelinating disorders (central and peripheral), balance disorders, dysgeusia, paresthesia[Ref]


Common (1% to 10%): Increased ALT and AST

Uncommon (0.1% to 1%): Cholelithiasis, hepatic disorders

Rare (less than 0.1%): Hepatitis B reactivation[Ref]


Common (1% to 10%): Anemia

Uncommon (0.1% to 1%): Leucopenia, thrombocytopenia, pancytopenia

Frequency not reported: Aplastic anemia[Ref]


Common (1% to 10%): Bacterial infections (such as cellulitis), viral infections (such as influenza and herpes), superficial fungal infections, autoantibody positive

Uncommon (0.1% to 1%): Septic shock, sepsis, opportunistic infections (e.g., invasive fungal infections [histoplasmosis, coccidioidomycosis, pneumocytosis], bacterial, atypical mycobacterial infection and protozoal), abscess

Rare (less than 0.1%): Sarcoidosis

Postmarketing reports: Autoimmune lupus-like syndrome[Ref]


Common (1% to 10%): Injection site reactions (e.g., injection site erythema, urticaria, induration, pain, bruising, irritation, paresthesia)[Ref]


Common (1% to 10%): Pruritus, rash

Uncommon (0.1% to 1%): Psoriasis (new onset or worsening of preexisting psoriasis, palmar/plantar and pustular), urticaria, vasculitis (cutaneous), alopecia, dermatitis

Rare (less than 0.1%): Skin exfoliation[Ref]


Common (1% to 10%): Allergic reactions (bronchospasm, urticaria)

Rare (less than 0.1%): Serious systemic hypersensitivity reactions (including anaphylactic reaction)[Ref]


Uncommon (0.1% to 1%): Hypothyroidism, hyperthyroidism, goiter[Ref]


Common (1% to 10%): Constipation, dyspepsia, gastrointestinal and abdominal pain, nausea

Uncommon (0.1% to 1%): Gastrointestinal inflammatory disorders (e.g., gastritis and colitis), gastroesophageal reflux disease, stomatitis[Ref]


Uncommon (0.1% to 1%): Breast disorders, menstrual disorders, bladder disorders[Ref]


Uncommon (0.1% to 1%): Increased blood glucose, increased lipids[Ref]


Uncommon (0.1% to 1%): Bacterial arthritis, bone fractures

Rare (less than 0.1%): Infective bursitis, lupus-like syndrome[Ref]


Uncommon (0.1% to 1%): Blurred vision, decreased visual acuity, conjunctivitis, eye allergy (e.g., pruritus, irritation)[Ref]


Uncommon (0.1% to 1%): Depression, insomnia[Ref]


Uncommon (0.1% to 1%): Renal disorders

Rare (less than 0.1%): Pyelonephritis[Ref]


1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Simponi (golimumab)." Centocor Inc, Malvern, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.